about
Radiation dosimetry and biodistribution in non-human primates of the sodium/iodide PET ligand [(18)F]-tetrafluoroborateNon-invasive in vivo imaging of cardiac stem/progenitor cell biodistribution and retention after intracoronary and intramyocardial delivery in a swine model of chronic ischemia reperfusion injury.Effective dose estimation for oncological and neurological PET/CT procedures.Ventricular wall granulations and draining of cerebrospinal fluid in chronic giant hydrocephalus.Cortical atrophy and language network reorganization associated with a novel progranulin mutation.Impact on dose and image quality of a software-based scatter correction in mammography.Monoaminergic PET imaging and histopathological correlation in unilateral and bilateral 6-hydroxydopamine lesioned rat models of Parkinson's disease: a longitudinal in-vivo study.Impact of time-of-flight and point-spread-function in SUV quantification for oncological PET.Statistical parametric maps of ¹⁸F-FDG PET and 3-D autoradiography in the rat brain: a cross-validation study.Decreased carbon-11-flumazenil binding in early Alzheimer's disease.New MRI, 18F-DOPA and 11C-(+)-alpha-dihydrotetrabenazine templates for Macaca fascicularis neuroimaging: advantages to improve PET quantification.PET optimization for improved assessment and accurate quantification of 90Y-microsphere biodistribution after radioembolization.Metabolic patterns in prion diseases: an FDG PET voxel-based analysis.Functional neuroimaging studies in asymmetric hearing loss.Activation of the brainstem but not of the hypothalamus in hemicrania continua without autonomic symptoms.Glucose metabolism during fasting is altered in experimental porphobilinogen deaminase deficiency.Successful thalamic deep brain stimulation for orthostatic tremor.Automated analysis of FDG PET as a tool for single-subject probabilistic prediction and detection of Alzheimer's disease dementia.Brain PET imaging optimization with time of flight and point spread function modelling.MRI fused with prone FDG PET/CT improves the primary tumour staging of patients with breast cancer.Twelve automated thresholding methods for segmentation of PET images: a phantom study.Significant dose reduction is feasible in FDG PET/CT protocols without compromising diagnostic quality.Quantitative volumetric analysis of gliomas with sequential MRI and ¹¹C-methionine PET assessment: patterns of integration in therapy planning.Voxel-based analysis of dual-time-point 18F-FDG PET images for brain tumor identification and delineation.[Neuroimaging: technical aspects and practice]Radiation dose produced by patients during radiopharmaceutical incorporation in nuclear medicine diagnostic proceduresPlasma Aβ42/40 ratio alone or combined with FDG-PET can accurately predict amyloid-PET positivity: a cross-sectional analysis from the AB255 Study18F-FDG and 11C-Methionine PET/CT in Newly Diagnosed Multiple Myeloma Patients: Comparison of Volume-Based PET Biomarkers18F-FDG-PET Imaging Patterns in Autoimmune Encephalitis: Impact of Image Analysis on the Results
P50
Q27321151-9D438545-8499-4F34-8F0F-F1BE87654350Q30841694-13310E36-AED1-4637-8C21-27EE0F78BEE9Q33599612-62C2A4EA-CF7E-4122-AC07-7E3D40318F7BQ34940640-AAD9B9EA-4774-4DE1-84F6-87115CCD0521Q38385539-751DFFD2-ACA5-43C9-B4DA-DBF552FF63ADQ40502186-9A6A8D94-8DC0-484A-8EC0-243477DFA2B4Q41436700-BEC58057-CD6D-45A7-953F-4E447FBF8AFAQ43613277-F2D0A7B1-4561-46C8-965D-F0836020C164Q43786146-2C3C2ED6-0CD4-4D31-918C-C816E2878561Q44014493-627FFA08-201D-4A9C-AEC1-87AB42193B1AQ46021600-6B93E1C8-27EA-4F96-8B5F-510A6F3B2B3BQ46667135-0814BA6E-F51F-4BF9-A2D2-0837B0BBDD08Q47967854-ABC950EB-E416-4651-A4BA-375B65EE644AQ48166286-C19C7039-E91C-44E5-A5E6-E280375FB2F9Q48707569-A43051E1-34AC-4A17-8175-07B5DA7ED593Q48882834-BC5F319D-13F9-4CA9-BDBF-397434B1060DQ49021359-44E76F77-B1E9-4600-A8B5-4ECD6AD5E746Q50479860-0D926E2E-B7F6-4101-8648-43B06E432AF2Q50870726-962461C4-347E-4293-8722-F31485824B53Q50996001-80FA2BEF-4E01-40BC-8979-9CEED6B7AC93Q51360763-A6EFA821-3F62-44CB-B361-D882A93DB04BQ51742686-4B1E142A-BCCE-4100-BA19-39D7906AF7DBQ55462330-1613EADB-6153-4059-814C-71A3EFC5938EQ55463088-F0D17171-BC92-45E6-B3F2-BCF680F932DCQ84480832-271DCB1D-CBBC-4035-94BB-E9E40748FCE4Q87047857-A29A5092-6A56-4B36-8A12-468DD41BF14AQ91578256-A6D346A8-04DA-4287-9B30-678FA6E65EACQ93263287-CD951814-8C96-4347-BEA3-C300DA0D0D0CQ96115575-35E16B83-9EFC-4939-B86E-BE73263505C8
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
E Prieto
@ast
E Prieto
@en
E Prieto
@es
E Prieto
@nl
type
label
E Prieto
@ast
E Prieto
@en
E Prieto
@es
E Prieto
@nl
altLabel
Elena Prieto
@en
prefLabel
E Prieto
@ast
E Prieto
@en
E Prieto
@es
E Prieto
@nl
P1053
N-2142-2014
P106
P1153
35620940700
P31
P496
0000-0002-3609-1210